Atlas Trials

Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer

Clinical trial NCT02501603 · COMPLETED

Trial details

NCT number
NCT02501603
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerGastroesophageal Junction Cancer
Start date
2016-07-01
Primary completion
2021-12-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.